It's not easy to interpret what exactly this means in terms of efficacy, but it seems like many are already jumping to conclusions. If paxalisib clearly didn't work it would be stopped for futility, which isn't the case. However, I think a conference call would be important to discuss the ramifications, good or bad, of this progress.
Add to My Watchlist
What is My Watchlist?